RxSpan MD review

The costs at a glance

Three different payment pathways

I would start with the $249 injection, not the cheapest product

The monthly semaglutide injection entry lists $249 and describes consultation, shipping and a 30-day supply containing 3 mg. Tirzepatide injection is listed separately at $329 monthly. Those are useful reference points because the treatment and billing unit are identified. They still do not settle the cost of every prescription. My first comparison would put the written quantity, prescribed dose and next refill beside the advertised number. A starting supply can be a poor guide to the budget later in treatment, especially if the prescription changes. Ask what remains included when it does. Build the full budget with our total GLP-1 cost guide.

The menu contains several different purchases

RxSpan's weight-loss page separates compounded injections and oral capsules from brand-name products. I would keep each on its own line when comparing offers. A capsule and an injection sharing an ingredient name do not become interchangeable purchases, and an approved brand has its own labeling and presentation. The deciding question is why the clinician recommends that exact preparation for you. An attractive catalog gives you options to discuss; it does not establish that every option is suitable, currently fulfillable in your state, or supported by the same evidence.

An ODT price needs its own explanation

The catalog also lists semaglutide orally disintegrating tablets at $179 per month and tirzepatide ODTs at $199 per month. I would not use either as the price of an injectable program. Before choosing an oral preparation, ask how it is administered, what evidence supports the actual formulation and how the prescriber will assess response. Convenience is a legitimate preference, but the convenience discussion should follow an explanation of the product. An ingredient-level study or a familiar brand name is not enough to answer those questions for a different compounded preparation. Separate the product categories in our branded versus compounded GLP-1 guide.

Multi-month entries do not settle the payment schedule

Several catalog items have three-, six- or twelve-month terms in their names. I would request a checkout document showing the full debit, supply schedule and renewal amount rather than dividing a product price and assuming monthly billing. That distinction matters if you change providers, cannot continue treatment or need a different prescription. A longer commitment can reduce an advertised equivalent while increasing the cash at risk. Compare the monthly option first, then decide whether the longer term buys enough confirmed value to justify that additional commitment. Model the commitment with our prepaid versus monthly calculator.

The no-prescription review fee is a question to resolve

The semaglutide injection description states a $50 medical-review fee if medication is not prescribed. A separate general telehealth-visit description lists an $80 consultation fee in that situation. I would not combine those into one universal policy or assume a zero-dollar catalog visit means care is always free. Ask which appointment path you are buying and save its fee disclosure before authorizing payment. This is a practical distinction for anyone uncertain about eligibility: the medical decision and the financial terms need to be clear before the assessment begins.

Ongoing access is useful when the escalation route is clear

The care overview advertises unlimited appointments and messaging, alongside expedited shipping. My follow-up question is how that access works after the first order. Ask whether a medication question reaches the prescribing clinician, how a live appointment is arranged and who handles problems with a delivered parcel. Messaging availability is useful, but it is not the same as a guaranteed response time or emergency service. I would value a clear route for obtaining clinical help more than a long list of access claims without an explanation of what happens next.

The general terms leave purchase details to confirm

RxSpan's terms describe independent medical professionals, prescription decisions after evaluation and responsibility for service fees. They do not provide a complete cancellation and prepaid-refund schedule in the document reviewed. I would ask for the terms attached to the chosen plan, including the last point at which an order can be stopped and how any unused commitment is treated. Saving those answers is particularly useful when a promotional price is involved. The fact that a plan has a monthly description does not, by itself, prove that every charge can be reversed.

Who should keep RxSpan on the shortlist?

I would shortlist RxSpan for someone willing to compare the precise prescription and purchase terms across a broad menu. I would slow down if the main appeal were simply the smallest displayed number, or if avoiding a possible review fee were essential. Request one itemized offer containing the product, quantity, first payment, next payment and cancellation boundary. Then compare an alternative with the same price scope. That makes the decision about the service you would actually receive, rather than a comparison between unrelated catalog entries or a promise of a particular clinical outcome.

Before you sign up

• Which exact formulation, quantity and billing term does my quote cover?
• What fee applies if no prescription is issued?
• What are the renewal, cancellation and unused-term refund rules?

Use the answers to compare the exact offer with another provider. A service review cannot determine whether a medication is appropriate for you; that decision belongs with your clinician.